(PharmaNewsWire.Com, February 25, 2021 ) Meticulous Research®– a leading global market research company published a research report titled “Hemodialysis and Peritoneal Dialysis Market by Product (Machines, Dialyzers, Bloodlines, Catheters, Concentrates), Type (Conventional, Daily, Nocturnal), and End User (Hospital, Clinics, & Dialysis Centers, and Home Use) – Global Forecast to 2027”. According to this latest publication from Meticulous Research®, the hemodialysis and peritoneal dialysis market is expected to grow at a CAGR of 4.4% from 2020 to $17.69 billion by 2027. The growing prevalence of kidney disorders, diabetes, and hypertension; the increasing number of dialysis centers; initiatives for chronic kidney care; and shortage of kidney transplants are majorly driving the hemodialysis and peritoneal dialysis market.
COVID-10 Leading to Increased Adoption of Home Dialysis
In the last few months, due to the COVID-19 pandemic, patients undergoing weekly therapy in dialysis facilities are concerned about their safety. These concerns are further expected to increase patient interest in home-based modalities. For those undergoing home dialysis, the pandemic has had a minimal impact. Many countries are recommending peritoneal dialysis, using telemedicine assistance or other communication systems whenever possible. Therefore, COVID-19 has a positive impact on the hemodialysis and peritoneal dialysis market.
The hemodialysis and peritoneal dialysis market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027. This market has been segmented on the basis of hemodialysis products [device (center-use and home-use) and consumables (dialyzers, bloodlines, concentrates/dialysates, and others)], peritoneal dialysis [device and consumables (concentrates/dialysates, catheters, and others)], type (conventional, short daily, and nocturnal) end user (hospitals, clinics, & dialysis centers and home dialysis)and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.
Based on the peritoneal dialysis product type, the consumables segment is estimated to account for the largest share of the overall market in 2020. The largest share of this segment is mainly attributed to increasing awareness regarding the advantages of peritoneal dialysis and its feasibility, leading to the use of consumables for both peritoneal dialysis types.
Based on type, the conventional segment is estimated to account for the largest share of the overall market in 2020. The largest share of this segment is mainly attributed to a surge in chronic kidney cases leading to a rise in patients moving towards conventional dialysis treatment. Also, this treatment, being traditional, is followed in every hospital and dialysis units.
On the basis of end user, the hemodialysis and peritoneal dialysis market is segmented into hospitals, clinics & dialysis centers, and home dialysis. Hospitals, clinics & dialysis centers are estimated to account for the largest share in 2020 due to the increasing number of hospitals and dialysis centers.
This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and the Middle East & Africa. North America is estimated to dominate the hemodialysis and peritoneal dialysis market in 2020, followed by Europe and Asia-Pacific. The growing number of ESRD cases, favorable reimbursement scenario, a large number of dialysis centers, and easy accessibility to technologically advanced dialysis products in the region are the factors driving the growth of this regional segment.
Key Players:
The key players operating in the hemodialysis and peritoneal dialysis market are Becton, Dickinson and Company (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), MEDTRONIC PUBLIC LIMITED COMPANY (Ireland), Nipro Corporation (Japan), and Toray Industries, Inc. (Japan)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
